Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,460 total articles
Parabilis (PBLS) just delivered Phase 1/2 proof-of-concept data for zolucatetide in desmoid tumors and secured FDA alignment on a Phase 3 program. With a market cap near $3.1B, ample cash from a blockbuster 2026 financing, and rising short interest, the stock is set up for a mid-to-long-term re-rating if zolucatetide's efficacy expands into other C…
Teradyne is benefitting from accelerating demand for automated test equipment (ATE) driven by AI infrastructure and memory testing. With robust free cash flow, clean balance sheet, and Q3 revenue/EPS expectations that still leave room for positive surprises, we upgrade TER to a long trade. Entry at $313.90, target $380, stop $275 — mid-term (45 tra…
Zscaler (ZS) is trading at strong momentum with AI-security narratives driving multiple expansion. Fundamentals support continued revenue growth, but valuation metrics (P/S ~12.7, P/FCF ~49.8) and an overbought technical setup suggest much of the AI upside is already reflected in the price. This trade idea lays out a mid-term short with clear entry…
CBRE reported a clean Q3 beat on EPS and moved aggressively into data center services with the Onnec acquisition. Fundamentals show healthy margins, modest leverage and stable contract-based revenue; valuation looks reasonable for a growth re-rate if M&A and outsourcing tails continue. We present a mid-term trade plan with clear entry, stop and tar…
Netflix has been punished after guidance and engagement worries, yet fundamentals remain strong: ~325 million subscribers, 34.6% operating margin, $11.4B free cash flow and a $266B enterprise valuation. The market is pricing much slower growth; this trade targets a recovery in engagement and a re-rating over the next 180 trading days.
Vir Biotechnology just locked a material collaboration with Gilead and carries two meaningful clinical readouts this quarter. The balance of cash, recent deal economics and an undervalued market cap vs. potential milestone upside argue for a mid-term long trade. This is a high-risk, catalyst-driven play: enter at $11.05, stop $9.00, target $15.00 o…
Tractor Supply's pet business recovery, delivery/digital traction and a targeted $75 million of cost reductions give the stock a credible path to re-expand margins and lift cash flow. With the shares trading at $32.53 and a reasonable 16.8x P/E, a disciplined mid-term long captures upside while limiting downside with a tight stop.
Broadcom is trading like its AI exposure is a single-customer bet on OpenAI. That fear overstates the companys downside: Broadcom has diversified AI revenue streams, strong free cash flow ($39.4B), and a still-large TAM runway. This trade idea takes a long stance with a clear entry, stop and target over a 180 trading-day horizon.
JPMorgan Chase (JPM) is a well-capitalized diversified bank trading at a mid-teens P/E and below historical premium multiples for its size. The combination of a $888B market cap, double-digit ROE, a near-2% yield, and constructive technicals supports a long trade. This plan targets continued multiple expansion and tailwinds from fee businesses and …
Blackstone's Q3 showed record assets under management ($1.37T), strong capital inflows ($63.3B) and fee momentum despite a temporary hit to distributable earnings. The private-credit scare appears overdone: liquidations and redemptions have been manageable and management is pivoting into long-dated AI infrastructure and insurance relationships that…
Robinhood (HOOD) trades at a $83.5B market cap and a stretched 40x P/E despite uneven revenue mix and a visible crypto revenue slump. Technical momentum is bearish (RSI 34, MACD negative) and short activity is substantial. We lay out a mid-term short trade with an entry at $93.00, stop at $108.00 and a target of $70.00 over ~45 trading days.
CG Oncology's cretostimogene program posted compelling Phase 3 and Phase 2 combination data this year, yielding high complete response rates and strong bladder preservation statistics. At a market cap of roughly $5.46B and a pullback to the low $60s, the stock offers a tactical long opportunity for investors who can tolerate biotech binary risk. Tr…
GrafTech's recent announcements around structural cost reduction and stronger customer price commitments give the stock a clear near-term catalyst. The company is targeting $20-25 million in annual savings by 2028 after closing its Monterrey plant, and management expects mid-single-digit price gains in Q4 2026. With a compact market cap of ~$279M a…
Gilat Satellite Networks (GILT) is trading at $7.63 with a market cap of $587.7M and a pipeline that includes defense orders, in-flight connectivity expansion, and the pending Comtech Satellite & Space acquisition. The business mix and recent wins argue for re-rating if the Comtech deal closes and revenue synergies materialize. This is a position t…
Ares Capital (ARCC) offers a fat yield and trades slightly below reported NAV, but near-term risk around marked-down loans, rising operating costs, and flat interest income argue for a neutral stance into Q3 earnings on 10/27/2026. For new buyers, wait for a pullback to $18.00; existing holders should use a measured stop at $17.40 and target a reve…
Uber's decision to step back from pursuing a deeper grocery tie-up with Instacart removes a strategic distraction and short-term capital commitment. The core business is generating strong free cash flow, rideshare and delivery still have room to reaccelerate, and sentiment is compressing valuation into an attractive entry. This trade targets a mid-…
Rollins (ROL) reported a modest Q3 miss driven by a temporary drop in digital search leads tied to AI-driven search behavior. Fundamentals — strong free cash flow, healthy margins pre-pressures, and a conservative balance sheet — support a tactical long. Trade plan provided for a mid-term rebound over 45 trading days.
Bonterra Energy (BNEFF) is trading at $5.03 into clear technical strength but with a history of heavy short interest. This trade picks a disciplined long exposure that leans on current momentum while protecting capital against strategy-driven downside. Entry $5.03, stop $4.40, target $6.50 over a mid-term horizon (45 trading days).
CECO Environmental has been punished after a period of heavy deal activity and integration noise. The stock is trading near its 52-week low despite a $1.82B backlog, a raised 2026 adjusted EBITDA target of $200-$225M, and Q2 adjusted EBITDA up 73% YoY to $40.2M. This is a tactical, defined-risk long trade that seeks to capture mean reversion and re…
TTM Technologies posted a Q3 revenue and earnings beat, guided to $6.5B-$6.75B for 2027 and is investing $400M in capacity for 2028. A near-term sell-off has pushed technicals into oversold territory and created a trading opportunity: the market is treating the company as if its revenue peak is already behind it. We think the peak is at least two y…
Quest Diagnostics reported a clean Q3 beat, raised 2026 guidance, and is reportedly rolling out a new Alzheimer's blood test. Fundamentals and momentum support a mid-term long swing trade. Manageable valuation, solid free cash flow and improving margins back the case, while reimbursement, execution risk on the Alzheimer’s test and leverage are the …
XP fell sharply on political headlines, but the company's asset-growth engine, diversified distribution and an $8.12B market cap make the stock a pragmatic swing trade. Entry at $15.76, stop at $13.50, target $22.00 over ~45 trading days balances upside with clear downside protection.
ASML is running the tightest inventory in the semiconductor equipment chain: strong orders, constrained capacity and a product mix dominated by EUV systems leave the company with pricing power and multi-year visibility. The stock has pulled back into lower momentum territory; we view the current price as an actionable entry for a long trade to capt…
Euroseas is locking in high-charter coverage and generating meaningful cash while its share price sits below book value. With a market cap of ~$438M, a PE of 3.4 and a 4.6% yield, the risk/reward for a tactical long looks attractive if you respect a clear stop. This trade idea lays out an entry at $66.57, a stop at $60.00 and a target of $80.00 ove…
Bank of Hawaii (BOH) looks positioned to benefit from higher-for-longer rates and steady credit metrics. The stock trades near $70.59 with a sub-1.0 debt-to-equity profile, a P/E around 13, and a dividend yield near 4%. We present a mid-term swing trade that buys into NII strength while protecting capital with a tight stop.
